bendamustine hydrochloride has been researched along with Benign Monoclonal Gammopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Lin, X; Xu, Q; Yu, J; Zhang, K | 1 |
| Fornecker, LM; Lipsker, D; Martin, M; Martin, T; Toussaint, E | 1 |
2 other study(ies) available for bendamustine hydrochloride and Benign Monoclonal Gammopathies
| Article | Year |
|---|---|
CB-LPD, MGUS, T-LGLL, and PRCA: A rare case report of 4 concomitant hematological disorders.
Topics: Aged; Anemia; Antineoplastic Agents; Bendamustine Hydrochloride; Bortezomib; Dexamethasone; Humans; Leukemia, Large Granular Lymphocytic; Lymphoproliferative Disorders; Male; Monoclonal Gammopathy of Undetermined Significance; Red-Cell Aplasia, Pure; Rituximab; Sirolimus | 2021 |
Bendamustine conditioning for refractory type I cryoglobulinemia.
Topics: Adult; Antineoplastic Agents, Alkylating; Autografts; Bendamustine Hydrochloride; Cryoglobulinemia; Female; Humans; Monoclonal Gammopathy of Undetermined Significance; Stem Cell Transplantation | 2016 |